statistiche ricercatore

Continente	#
NA - Nord America	1.619
EU - Europa	559
AS - Asia	413
SA - Sud America	36
AF - Africa	22
Continente sconosciuto - Info sul continente non disponibili	15
Totale	2.664

Nazione	#
US - Stati Uniti d'America	1.573
CN - Cina	173
RU - Federazione Russa	119
SG - Singapore	115
DE - Germania	105
IT - Italia	66
PL - Polonia	63
GB - Regno Unito	55
FR - Francia	45
HK - Hong Kong	38
CA - Canada	33
BR - Brasile	32
UA - Ucraina	30
SE - Svezia	25
VN - Vietnam	22
FI - Finlandia	15
ZA - Sudafrica	14
KR - Corea	13
TR - Turchia	13
BE - Belgio	10
IE - Irlanda	7
JP - Giappone	7
BD - Bangladesh	6
IN - India	5
ES - Italia	4
KE - Kenya	4
GT - Guatemala	3
IL - Israele	3
JO - Giordania	3
LT - Lituania	3
PK - Pakistan	3
TT - Trinidad e Tobago	3
AE - Emirati Arabi Uniti	2
DZ - Algeria	2
JM - Giamaica	2
MX - Messico	2
NL - Olanda	2
RO - Romania	2
SA - Arabia Saudita	2
SK - Slovacchia (Repubblica Slovacca)	2
VE - Venezuela	2
AM - Armenia	1
AZ - Azerbaigian	1
EC - Ecuador	1
EE - Estonia	1
EU - Europa	1
GD - Grenada	1
GR - Grecia	1
HR - Croazia	1
IR - Iran	1
KH - Cambogia	1
LV - Lettonia	1
MD - Moldavia	1
MY - Malesia	1
NI - Nicaragua	1
PH - Filippine	1
PR - Porto Rico	1
RS - Serbia	1
SC - Seychelles	1
TH - Thailandia	1
TN - Tunisia	1
UY - Uruguay	1
UZ - Uzbekistan	1
Totale	2.650

Nome	#
Synthesis and antitumor evaluation of bis aza-anthracene-9,10-diones and bis aza-anthrapyrazole-6-ones	309
Adenine based acyclic-nucleotides as novel P2X3 receptor ligands	307
Neuropeptide S Receptor: recent updates on non-peptide antagonist discovery	298
Synthesis and biological evaluation of indazolo[4,3-bc][1,5]naphthyridines (10-aza-pyrazolo[3,4,5-kl]acridines): a new class of antitumor agents.	298
Rational Design, Synthesis and Biological Evaluation of Bis(pyrimido[5,6,1-de]acridines) and Bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as New Anticancer Agents	275
8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A(2A) and A(2B) receptors ligands	249
Design, synthesis, and biological evaluation of new mitonafide derivatives as potential antitumor drugs	246
Synthesis and biological evaluation of new asymmetrical bisintercalators as potential antitumor drugs	235
Molecular modeling studies on the human neuropeptide S receptor and its antagonists.	233
The role of structural factors in the kinetics of cellular uptake of pyrazoloacridines and pyrazolopyrimidoacridines. Implications for overcoming multidrug resistance towards leukaemia K562/DOX cells	214
Totale	2.664

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	89	0	0	0	6	8	11	9	6	11	17	5	16
2022/2023	176	19	12	11	36	13	27	0	9	27	6	10	6
2023/2024	116	18	3	8	5	5	22	2	6	10	1	3	33
2024/2025	300	10	7	20	13	5	25	38	74	24	15	18	51
2025/2026	495	24	26	48	96	67	41	79	39	14	34	21	6
2026/2027	173	35	16	47	75	0	0	0	0	0	0	0	0
Totale													2.664